The febrile neutropenia treatment market is expanding due to increasing oncology treatments and prophylactic use of growth factors like G‑CSF, along with broad antibiotic protocols and supportive care advances. https://www.datamintelligence.com/research-report/febrile-neutropenia-treatment-market